| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $132K | +51.2% |
| R&D Expense | $10.1M | -4.9% |
| SG&A Expense | $4.5M | -15.1% |
| Operating Income | -$14.4M | +8.6% |
| Interest Expense | $15K | -4.1% |
| Pre-tax Income | -$14.3M | +9.1% |
| Net Income | -$14.3M | +9.1% |
| EPS (Basic) | -$7.11 | -4978.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.4M | -58.1% |
| Current Assets | $14.3M | -48.4% |
| Total Assets | $14.8M | -47.7% |
| Current Liabilities | $1.6M | +10.4% |
| Stockholders' Equity | $13.0M | -50.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.2M | -13.1% |
| Capital Expenditures | $128K | +190.6% |
| Investing Cash Flow | -$116K | -163.3% |
| Financing Cash Flow | -$495K | -102.1% |
| Free Cash Flow | -$15.4M | -13.6% |